[1] Zhao Q, Li J, Wu B, et al. Smart Biomimetic Nanocomposites Mediate Mitochondrial Outcome through Aerobic Glycolysis Reprogramming: A Promising Treatment for Lymphoma. ACS Appl Mater Interfaces. 2020;12(20):22687-22701. doi:10.1021/acsami.0c05763(IF:9.229)
[2] Zou Q, Xiao Z, Huang R, et al. Survey of the translation shifts in hepatocellular carcinoma with ribosome profiling. Theranostics. 2019;9(14):4141-4155. Published 2019 May 31. doi:10.7150/thno.35033(IF:8.063)
[3] Li Q, Tan Q, Ma Y, Gu Z, Chen S. Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress. Front Oncol. 2022;12:903394. Published 2022 May 11. doi:10.3389/fonc.2022.903394(IF:6.244)
[4] Huang T, Fan Q, Wang Y, et al. Schwann Cell-Derived CCL2 Promotes the Perineural Invasion of Cervical Cancer. Front Oncol. 2020;10:19. Published 2020 Jan 29. doi:10.3389/fonc.2020.00019(IF:6.244)
[5] Li B, Wei S, Yang L, et al. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma. Front Oncol. 2021;11:657723. Published 2021 Aug 16. doi:10.3389/fonc.2021.657723(IF:6.244)
[6] Zhao R, Bei X, Yang B, et al. Endothelial cells promote metastasis of prostate cancer by enhancing autophagy. J Exp Clin Cancer Res. 2018;37(1):221. Published 2018 Sep 10. doi:10.1186/s13046-018-0884-2(IF:6.217)
[7] Li J, Zhi X, Chen S, et al. CDK9 inhibitor CDKI-73 is synergetic lethal with PARP inhibitor olaparib in BRCA1 wide-type ovarian cancer. Am J Cancer Res. 2020;10(4):1140-1155. Published 2020 Apr 1. (IF:5.177)
[8] Cai C, Dang W, Liu S, et al. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway. Cancer Sci. 2020;111(4):1132-1145. doi:10.1111/cas.14326(IF:4.966)
[9] Gao Y, Wang Z, Zhu Y, et al. NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma. Cancer Sci. 2019;110(11):3510-3519. doi:10.1111/cas.14190(IF:4.751)
[10] Zai W, Chen W, Han Y, et al. Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma. Carcinogenesis. 2020;41(3):345-357. doi:10.1093/carcin/bgz104(IF:4.603)
[11] Cai Y, Lv F, Kaldybayeva N, Zhamilya A, Wu Z, Wu Y. 15, 16-Dihydrotanshinone I Inhibits Hemangiomas through Inducing Pro-apoptotic and Anti-angiogenic Mechanisms in Vitro and in Vivo. Front Pharmacol. 2018;9:25. Published 2018 Jan 30. doi:10.3389/fphar.2018.00025(IF:3.831)
[12] Li Q, Xu D, Gu Z, Li T, Huang P, Ren L. Rutin restrains the growth and metastasis of mouse breast cancer cells by regulating the microRNA-129-1-3p-mediated calcium signaling pathway. J Biochem Mol Toxicol. 2021;35(7):e22794. doi:10.1002/jbt.22794(IF:3.652)
[13] Wang L, Hao J, Zhang Y, et al. Orai1 mediates tumor-promoting store-operated Ca2+ entry in human gastrointestinal stromal tumors via c-KIT and the extracellular signal-regulated kinase pathway. Tumour Biol. 2017;39(2):1010428317691426. doi:10.1177/1010428317691426(IF:3.650)
[14] Dong L, Lin W, Qi P, et al. Circulating Long RNAs in Serum Extracellular Vesicles: Their Characterization and Potential Application as Biomarkers for Diagnosis of Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1158-1166. doi:10.1158/1055-9965.EPI-16-0006(IF:3.622)
[15] Li C, Xia M, Wang H, Li W, Peng J, Jiang H. Propofol facilitates migration and invasion of oral squamous cell carcinoma cells by upregulating SNAI1 expression. Life Sci. 2020;241:117143. doi:10.1016/j.lfs.2019.117143(IF:3.448)
[16] Zhang TT, Qu N, Sun GH, et al. NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer. Int J Oncol. 2018;53(2):685-693. doi:10.3892/ijo.2018.4426(IF:3.333)
[17] Sun X, Zhou J, Zhang Z. Cullin 4A/protein arginine methyltransferase 5 (CUL4A/PRMT5) promotes cell malignant phenotypes and tumor growth in nasopharyngeal carcinoma. Bioengineered. 2022;13(4):8712-8723. doi:10.1080/21655979.2022.2054756(IF:3.269)
[18] Jian W, Deng XC, Munankarmy A, et al. KIF23 promotes triple negative breast cancer through activating epithelial-mesenchymal transition. Gland Surg. 2021;10(6):1941-1950. doi:10.21037/gs-21-19(IF:2.953)
[19] Li J, Zhi X, Shen X, et al. Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1. Biochem Biophys Res Commun. 2020;523(2):434-440. doi:10.1016/j.bbrc.2019.12.058(IF:2.705)
[20] Zhong J, Lin R, Wang G, Lin L, Ruan S, Liu W. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway. Tissue Cell. 2022;75:101739. doi:10.1016/j.tice.2022.101739(IF:2.466)
[21] Wu M, Guo Q, Liu X, Wu L. SPRR3, a novel miR-338-3p target, regulates the malignant progression of clear cell renal cell carcinoma in vitro via the PI3K/Akt signaling pathway. Exp Ther Med. 2022;23(5):317. doi:10.3892/etm.2022.11246(IF:2.447)
